Pages that link to Safety Assessment of Supplementation with Cymbopogon citratus Stapf. (Lemongrass) Extract in Patients with Chronic Kidney Disease Stage 3: A Preliminary 90-Days Prospective Study

Primary tabs

Cite This Article

Vancouver Style ::
Wongmanit P, Tungsukruthai P, Phetkate P, Rungprai D, Tungsukruthai S, Supasyndh O, et al. Safety Assessment of Supplementation with Cymbopogon citratus Stapf. (Lemongrass) Extract in Patients with Chronic Kidney Disease Stage 3: A Preliminary 90-Days Prospective Study. Pharmacognosy Journal. 2023;15(6):976-986.PDF icon PDF (872.73 KB)
No backlinks found.

Copyright © 2020 Pharmacogn J. All rights reserved.

Pharmacognosy Journal and its contents are licensed under a Creative Commons Attribution-Non Commercial-No Derivs 4.0 License. Permissions beyond the scope of this license may be available with  editor@phcogj.com